Finanical Statements
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA.CA) Reports 6 Months Consolidated Results
Published at 16 August 2026 at 08:15Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-RamedaRelated stock:Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda stockAll Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda disclosures
Disclosure summary
Company Name : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 204,297,278
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 185,268,309
Audit Status : Reviewed
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in English (741 KB)
The Financial Statements in Arabic (1,066 KB)
ISIN Code : EGS381B1C015
Currency : EGP
F/S Consolidated Period : From 01/01/2026 To 30/06/2026
Net Profit : 204,297,278
F/S Consolidated Period : From 01/01/2025 To 30/06/2025
Net Comparative Profit : 185,268,309
Audit Status : Reviewed
Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
The Financial Statements in English (741 KB)
The Financial Statements in Arabic (1,066 KB)